4//SEC Filing
ProNAi Therapeutics Inc 4
Accession 0001209191-16-092226
CIK 0001290149operating
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:00 PM ET
Size
9.4 KB
Accession
0001209191-16-092226
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Exercise/Conversion
Common Stock
2016-01-15$0.97/sh+5,000$4,845→ 5,000 total - Exercise/Conversion
Stock Option (right to buy)
2016-01-15−5,000→ 864,219 totalExercise: $0.97Exp: 2024-07-13→ Common Stock (5,000 underlying) - Sale
Common Stock
2016-01-15$10.04/sh−5,000$50,223→ 0 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.29 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vests as to 25% of the total shares on July 14, 2015, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on July 14, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. The option is immediately exercisable.
Documents
Issuer
ProNAi Therapeutics Inc
CIK 0001290149
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001290149
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 7:00 PM ET
- Size
- 9.4 KB